(MENAFN- America News Hour) Market Study Report Provides A Detailed Overview Of Drug
Discovery Informatics Market With Respect To The Pivotal Drivers Influencing
The Revenue Graph Of This Business Sphere. The Current Trends Of Drug Discovery
Informatics Market In Conjunction With The Geographical Landscape, Demand
Spectrum, Remuneration Scale, And Growth Graph Of This Vertical Have Also Been
Included In This Report.
Global Drug Discovery Informatics Market is valued
approximately USD 1.89 billion in 2018 and is anticipated to grow with a
healthy growth rate of more than 11.20% over the forecast period 2019-2026.
Request a sample of this premium report titled at @ https://www.marketstudyreport.com/request-a-sample/2453087/
The objective of the study is to define market sizes of
different segments & countries in recent years and to forecast the values
to the coming eight years. The report is designed to incorporate both
qualitative and quantitative aspects of the industry within each of the regions
and countries involved in the study. Furthermore, the report also caters the
detailed information about the crucial aspects such as driving factors &
challenges which will define the future growth of the market. Additionally, the
report shall also incorporate available opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive
landscape and product offerings of key players. The detailed segments and
sub-segment of the market are explained below:
By Function: (Sequencing & Target Data Analysis,
Docking, Molecular Modelling, Libraries & Database Preparation, Other
Functions)
By Solution: (Software, Services)
By End-User: (Pharmaceutical and Biotechnology
Companies, Contract Research Organizations (CROS), Others End Users)
Drug discovery informatics is a functional process performed
by biotechnology and pharmaceutical companies that requires the generation of
very large data and information. Through application of modern engineering and
computational approaches the models are analyzed, visualized and simulated for
pharmacological profiling. Further, rising R & D expenditure on
pharmaceuticals along with the increasing government focus on drug discovery
are some key forces, driving the growth of the drug discovery informatics
market over the forecast period of 2019-2026. For instance: According to the
U.K. government in 2016, drug development sector and continuous manufacturing
would receive funds around USD 82.5 million from government and private sources
as part of its new USD 188 million effort and 'Industry Strategy' to establish
six key research hubs in UK to boost research and development activities
related to drug discovery. As a result, the adoption of the drug discovery
informatics would increase thereby, contributing towards the growth of the
market. However, high pricing and set up cost of informatics software impede
the growth of the global drug discover informatics market.
Target Audience of the Global Drug Discovery Informatics
Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global drug discovery informatics
market is considered for the key regions such as Asia Pacific, North America,
Europe, Latin America and Rest of the World. North America is the
leading/significant region across the world in terms of market share owing to
well-established healthcare infrastructure along with the presence of various
biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to
exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to
availability of low cost of human resources and manufacturing and availability
of many qualified researchers. Also, the growth of the Asia-Pacific region is
attributed owing to the ongoing drug development activities undertaken by
government.
Major market player included in this report are:
Jubilant Life Sciences
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
Schrödinger
Dassault Systèmes
Charles River Laboratories
GVK Biosciences
Boehringer Ingelheim GmbH
Furthermore, years considered for the study are as
follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Request a discount on standard prices of this premium report titled at @ https://www.marketstudyreport.com/check-for-discount/2453087/
Table of Contents:
Chapter 1. Executive
Summary
1.1. Market
Snapshot
1.2. Key Trends
1.3. Global
& Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1. Drug
Discovery Informatics Market, by Function, 2016-2026 (USD Million)
1.3.2. Drug
Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
1.3.3. Drug
Discovery Informatics Market, by End-user 2016-2026 (USD Million)
1.3.4. Drug
Discovery Informatics Market, by Region, 2016-2026 (USD Million)
1.4. Estimation
Methodology
1.5. Research
Assumption
Chapter 2. Global
Drug Discovery Informatics Market Definition and Scope
2.1. Objective
of the Study
2.2. Market
Definition & Scope
2.2.1. Industry
Evolution
2.2.2. Scope of the
Study
2.3. Years
Considered for the Study
2.4. Currency
Conversion Rates
Chapter 3. Global
Drug Discovery Informatics Market Dynamics
3.1. See Saw
Analysis
3.1.1. Market
Drivers
3.1.2. Market
Challenges
3.1.3. Market
Opportunities
Chapter 4. Global
Drug Discovery Informatics Market Industry Analysis
4.1. Porter's 5
Force Model
4.1.1. Bargaining
Power of Buyers
4.1.2. Bargaining
Power of Suppliers
4.1.3. Threat of
New Entrants
4.1.4. Threat of
Substitutes
4.1.5. Competitive
Rivalry
4.1.6. Futuristic
Approach to Porter's 5 Force Model
4.2. PEST
Analysis
4.2.1. Political
Scenario
4.2.2. Economic
Scenario
4.2.3. Social
Scenario
4.2.4. Technological
Scenario
4.3. Key Buying
Criteria (On Demand)
4.4. Regulatory
Framework (On Demand)
4.5. Investment
Vs Adoption Scenario (On Demand)
4.6. Analyst
Recommendation & Conclusion
Chapter 5. Global
Drug Discovery Informatics Market, by Function
5.1. Market
Snapshot
5.2. Market
Performance - Potential Model
5.3. Drug
Discovery Informatics Market, Sub Segment Analysis
5.3.1. Sequencing
& Target Data Analysis
5.3.1.1. Market
estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.2. Docking
5.3.2.1. Market
estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.3. Molecular
Modelling
5.3.3.1. Market
estimates & forecasts, 2016-2026 (USD Million)
5.3.3.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.4. Libraries
& Database Preparation
5.3.4.1. Market
estimates & forecasts, 2016-2026 (USD Million)
5.3.4.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.5. Other Functions
5.3.5.1. Market
estimates & forecasts, 2016-2026 (USD Million)
5.3.5.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 6. Global
Drug Discovery Informatics Market, by Solution
6.1. Market
Snapshot
6.2. Market
Performance - Potential Model
6.3. Drug
Discovery Informatics Market, Sub Segment Analysis
6.3.1. Software
6.3.1.1. Market
estimates & forecasts, 2016-2026 (USD Million)
6.3.1.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.2. Services
6.3.2.1. Market
estimates & forecasts, 2016-2026 (USD Million)
6.3.2.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 7. Global
Drug Discovery Informatics Market, by End User
7.1. Market
Snapshot
7.2. Market
Performance - Potential Model
7.3. Drug
Discovery Informatics Market, Sub Segment Analysis
7.3.1. Pharmaceutical
and Biotechnology Companies
7.3.1.1. Market
estimates & forecasts, 2016-2026 (USD Million)
7.3.1.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2. Contract
Research Organizations (CROS)
7.3.2.1. Market
estimates & forecasts, 2016-2026 (USD Million)
7.3.2.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.3. Others End
Users
7.3.3.1. Market
estimates & forecasts, 2016-2026 (USD Million)
7.3.3.2. Regional
breakdown estimates & forecasts, 2016-2026 (USD Million)
For More Details On this Report at @ https://www.marketstudyreport.com/reports/global-drug-discovery-informatics-market-size-research
Related Report:
Global Healthcare Virtual Assistant Market Size study, By
Product (Smart Speakers and Chatbots), By User-Interface (Automatic Speech
Recognition, Text-Based, Text-To-Speech and others), By End-user (Healthcare
Providers, Healthcare Payers, Patients and other end-users) and Regional
Forecasts 2019-2026
Global Healthcare Virtual Assistant Market is valued
approximately USD 290.47 million in 2018 and is anticipated to grow with a
healthy growth rate of more than 34.6% over the forecast period 2019-2026.
Healthcare virtual assistant are used in the healthcare industry to organize
and raise patient data to a higher standard.
Also, these systems facilitate healthcare organization to collect
tolerant health history, demographics in order, finance/ costing, insurance
details, procurement details, data mining and others analysis of all the
records. The growth of the healthcare virtual assistant market is attributed
owing to the increasing smartphone penetration and growing use of healthcare
apps along with the need to curtail healthcare costs and medical errors.
For More Details On this Report at @ https://www.marketstudyreport.com/reports/global-healthcare-virtual-assistant-market-size-research
Read More Reports On: https://www.marketwatch.com/press-release/specialty-food-ingredients-market-size-growth-forecast-poised-to-touch-usd-6776-billion-by-2026-2019-12-16
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog
Market Study Report LLC
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
MENAFN22012020007010068ID1099587704
-MENAFN22012020007010068ID1099587704-->